-
公开(公告)号:US20060019964A1
公开(公告)日:2006-01-26
申请号:US11112048
申请日:2005-04-22
申请人: Ranchael Ancliff , Colin Eldred , Yvonne Fogden , Ashley Hancock , Thomas Heightman , Heather Hobbs , Simon Hodgson , Matthew Lindon , David Wilson
发明人: Ranchael Ancliff , Colin Eldred , Yvonne Fogden , Ashley Hancock , Thomas Heightman , Heather Hobbs , Simon Hodgson , Matthew Lindon , David Wilson
IPC分类号: A61K31/496 , C07D403/02
CPC分类号: C07D211/46
摘要: 1-{4-[(1-Cyclobutyl-4-piperidinyl)oxy]phenyl}-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine or a derivative thereof.
摘要翻译: 1- {4 - [(1-环丁基-4-哌啶基)氧基]苯基} -4 - {[4-(甲基磺酰基)苯基]羰基}哌嗪或其衍生物。
-
公开(公告)号:US08357716B2
公开(公告)日:2013-01-22
申请号:US13202139
申请日:2010-02-24
申请人: Heather Hobbs , Simon Teanby Hodgson , Yannick Maurice LaCroix , Deborah Needham , Nigel James Parr , Panayiotis Alexandrou Procopiou , Timothy John Ritchie , Michael David Woodrow
发明人: Heather Hobbs , Simon Teanby Hodgson , Yannick Maurice LaCroix , Deborah Needham , Nigel James Parr , Panayiotis Alexandrou Procopiou , Timothy John Ritchie , Michael David Woodrow
IPC分类号: A61K31/416 , C07D231/56
CPC分类号: C07D409/12 , C07D409/14 , C07D413/14
摘要: Indazole compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing such compounds and their use in therapy.
摘要翻译: 吲唑化合物,其制备方法,可用于这些方法的中间体,含有这些化合物的药物组合物及其在治疗中的用途。
-
公开(公告)号:US20120015932A1
公开(公告)日:2012-01-19
申请号:US13202139
申请日:2010-02-24
申请人: Heather Hobbs , Simon Teanby Hodgson , Yannick Maurice LaCroix , Deborah Needham , Nigel James Parr , Panayiotis Alexandrou Procopiou , Timothy John Ritchie , Michael David Woodrow
发明人: Heather Hobbs , Simon Teanby Hodgson , Yannick Maurice LaCroix , Deborah Needham , Nigel James Parr , Panayiotis Alexandrou Procopiou , Timothy John Ritchie , Michael David Woodrow
IPC分类号: A61K31/416 , C07D413/14 , C07D409/14 , A61K31/5377 , A61P29/00 , A61K31/496 , A61K31/422 , A61K31/4178 , A61P37/00 , C07D409/12 , A61K31/454
CPC分类号: C07D409/12 , C07D409/14 , C07D413/14
摘要: Indazole compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing such compounds and their use in therapy.
摘要翻译: 吲唑化合物,其制备方法,可用于这些方法的中间体,含有这些化合物的药物组合物及其在治疗中的用途。
-
公开(公告)号:US20090105309A1
公开(公告)日:2009-04-23
申请号:US10595432
申请日:2004-10-20
IPC分类号: A61K31/44 , C07C233/64 , A61K31/165 , C07C311/12 , A61K31/18 , A61P11/00 , C07C211/26 , A61K31/135 , C07D213/24
CPC分类号: C07C311/08 , C07C217/60 , C07C235/42 , C07D213/65
摘要: Compounds of formula (I): and salts, solvates, and physiologically functional derivatives thereof, useful for the prophylaxis or treatment of a clinical condition for which a selective β2-adrenoreceptor agonist is indicated, for example asthma or chronic obstructive pulmonary disease (COPD).
摘要翻译: 式(I)化合物及其盐,溶剂化物和生理功能衍生物可用于预防或治疗选择性β2-肾上腺素受体激动剂的临床状况,例如哮喘或慢性阻塞性肺病(COPD) 。
-
-
-